PURPOSE: To assess the spatial variability of a bladder tumor relative to the planning target volume boundaries during radical radiotherapy, and furthermore to develop strategies to reduce spatial variability. METHODS AND MATERIALS: Seventeen patients with solitary T2-T4N0M0 bladder cancer were treated with a technique delivering 40 Gy/2 Gy in 20 fractions to the whole bladder with a concomitant boost to the bladder tumor of 20 Gy in 1 Gy fractions in an overall time of 4 weeks. CT scans were made weekly, immediately after treatment, and matched with the planning CT scan. Spatial variability of the tumor, as well as bladder volume and rectal diameter, were scored for each patient each week. RESULTS: In 65% of patients, a part of the tumor appeared outside the planning target volume boundaries at least one time during the course of radiotherapy. No consistent relation of this variability with time was found. Bladder volumes and rectal diameters showed marked variability during the course of treatment. A large initial bladder volume and rectal diameter predicted a large volume variation and a large tumor spatial variability. CONCLUSION: In this study, a margin of 1.5 to 2 cm seemed to be inadequate in 65% of the patients with respect to spatial variability. Bladder volume and rectal diameter were found to be predictive for spatial variability of a bladder tumor during concomitant boost radiotherapy.
PURPOSE: To assess the spatial variability of a bladder tumor relative to the planning target volume boundaries during radical radiotherapy, and furthermore to develop strategies to reduce spatial variability. METHODS AND MATERIALS: Seventeen patients with solitary T2-T4N0M0 bladder cancer were treated with a technique delivering 40 Gy/2 Gy in 20 fractions to the whole bladder with a concomitant boost to the bladder tumor of 20 Gy in 1 Gy fractions in an overall time of 4 weeks. CT scans were made weekly, immediately after treatment, and matched with the planning CT scan. Spatial variability of the tumor, as well as bladder volume and rectal diameter, were scored for each patient each week. RESULTS: In 65% of patients, a part of the tumor appeared outside the planning target volume boundaries at least one time during the course of radiotherapy. No consistent relation of this variability with time was found. Bladder volumes and rectal diameters showed marked variability during the course of treatment. A large initial bladder volume and rectal diameter predicted a large volume variation and a large tumor spatial variability. CONCLUSION: In this study, a margin of 1.5 to 2 cm seemed to be inadequate in 65% of the patients with respect to spatial variability. Bladder volume and rectal diameter were found to be predictive for spatial variability of a bladder tumor during concomitant boost radiotherapy.
Authors: Jason A Efstathiou; Anthony L Zietman; Donald S Kaufman; Niall M Heney; John J Coen; William U Shipley Journal: World J Urol Date: 2006-11 Impact factor: 4.226
Authors: Dominique C van Rooijen; René Pool; Jeroen B van de Kamer; Maarten C C M Hulshof; Caro C E Koning; Arjan Bel Journal: Radiat Oncol Date: 2010-06-15 Impact factor: 3.481
Authors: David J Byun; Daniel J Gorovets; Lauren M Jacobs; Laura Happersett; Pengpeng Zhang; Xin Pei; Sarah Burleson; Zhigang Zhang; Margie Hunt; Sean McBride; Marisa A Kollmeier; Michael J Zelefsky Journal: Radiat Oncol Date: 2020-10-16 Impact factor: 3.481
Authors: Adham Hijab; Boris Tocco; Ian Hanson; Hanneke Meijer; Christina Junker Nyborg; Anders Smedegaard Bertelsen; Robert Jan Smeenk; Gillian Smith; Jeff Michalski; Brian C Baumann; Shaista Hafeez Journal: Front Oncol Date: 2021-02-25 Impact factor: 6.244
Authors: Dominique C van Rooijen; Jeroen B van de Kamer; René Pool; Maarten C C M Hulshof; Caro C E Koning; Arjan Bel Journal: Radiat Oncol Date: 2009-09-24 Impact factor: 3.481
Authors: Maurice M Garcia; Alexander R Gottschalk; Jonathan Brajtbord; Badrinath R Konety; Maxwell V Meng; Mack Roach; Peter R Carroll Journal: PLoS One Date: 2014-03-03 Impact factor: 3.240
Authors: A Hunt; I Hanson; A Dunlop; H Barnes; L Bower; J Chick; C Cruickshank; E Hall; T Herbert; R Lawes; D McQuaid; H McNair; A Mitchell; J Mohajer; T Morgan; U Oelfke; G Smith; S Nill; R Huddart; S Hafeez Journal: Clin Transl Radiat Oncol Date: 2020-09-11